港股科技股普漲 首批恆生科技ETF上市 迎增量資金
格隆匯5月26日丨港股科技股繼續普漲,恆生科技指數繼昨日收漲1.62%後,今日盤中再度漲1.1%。截至半日收盤,大市值科技股中,騰訊漲1.31%,阿里巴巴漲近1%,美團行近3%,京東漲1.4%,小米漲0.72%,百度漲1.55%;另外,鴻騰精密和閲文漲超6%領漲恆生科技指數成分股。昨日,華夏、易方達、博時旗下3只恆生科技ETF率先上市交易,大成和華安旗下2只產品也即將於5月27日上市。業內人士稱,首批恆生科技ETF的上市,將為港股科技股引來一定的增量資金。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.